Shave of Viveve Medical Inc. (VIVE) sank 9.7% toward a record low in premarket trading Friday, after the provider of health products and women's health services filed for the sale of new common stock to the public. The number of Class A common shares or Class B preferred shares the company will sell, or at what price the shares will be sold, has not yet been determined, according to a filing with the Securities and Exchange Commission. The stock has plummeted 91% over the past three months through Thursday, while the S&P 500 has eased 2.1%.
-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
October 11, 2019 08:49 ET (12:49 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.